Healthy Data Management: Essential Strategies for Governing PHI, PII, and Highly Sensitive Data during an Acquisition or Divestiture

The merger and divestiture process for any type of company raises issues of data management and protection, particularly with the ease employees use technology to collect, store, and use data. Due to the nature of the confidential data that health care, life sciences, and pharmaceutical companies create and retain, these types of organizations face higher standards and specific issues related to the retention and protection of data when engaged in the merger or divestiture transaction process. Companies must balance the demand for access and sharing of data to meet business needs with legal and compliance obligations to protect highly sensitive data.

Join this webinar for a 60-minute panel discussion covering the information governance life cycle for health care, life sciences, and pharmaceutical companies, from identification of sensitive data to storing and protecting that data during mergers and divestitures. You will gain insight on how to effectively manage and store your data as well as tips for developing an information governance program designed specifically to handle the type of sensitive data your health-focused company maintains.

Elliot Golding is speaking at this webinar.